DrFirst
DrFirst is a provider of software solutions tailored for healthcare professionals, including physicians, pharmacies, hospitals, and post-acute care facilities. The company's offerings encompass e-prescribing, medical data management, and electronic health records (EHR), with a focus on enhancing communication and collaboration among caregivers. By enabling real-time access to patient data, DrFirst aims to improve the clinical view of patients, thereby facilitating better health outcomes. Additionally, its HIPAA-compliant secure messaging system and tools for hospital medication reconciliation contribute to more efficient healthcare delivery and patient management.
VisibilityRx utilizes proprietary HIPAA compliant technology to build de-identified patient databases containing actual patient attributes. Reviewing this data set for characteristics that match actual project level protocol inclusion and exclusion criteria allows us to quickly and efficiently find patients that would benefit from your HIPAA compliant message.
The IN Group, Inc. specializes in providing information systems and workflow redesign consulting services tailored for the hospital sector, particularly those utilizing MEDITECH systems. Established in 2004 and headquartered in San Diego, California, the company offers a comprehensive range of services including implementation, optimization, and upgrade support for advanced clinical systems. Additionally, it provides custom report writing services, regulatory compliance assistance, and integration of clinical and financial solutions into MEDITECH electronic health records. The IN Group also supports hospitals in adapting to new payment models, including Patient-Centered Medical Home and Accountable Care initiatives. As of 2016, the company operates as a subsidiary of DrFirst.com, Inc.
iPrescribe.net is a mobile e-prescribing application for iOS and Android devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.